CVE-2017-1301

Description

IBM Spectrum Protect 7.1 and 8.1 could allow a local attacker to launch a symlink attack. IBM Spectrum Protect Backup-archive Client creates temporary files insecurely. A local attacker could exploit this vulnerability by creating a symbolic link from a temporary file to various files on the system, which could allow the attacker to overwrite arbitrary files on the system with elevated privileges. IBM X-Force ID: 125163.

Category

5.5
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.10%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Spectrum Protect
Published at:
Updated at:

References

Link Tags
http://www.ibm.com/support/docview.wss?uid=swg22006248 patch vendor advisory
http://www.securityfocus.com/bid/101107 vdb entry third party advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/125163 vdb entry vendor advisory

Frequently Asked Questions

What is the severity of CVE-2017-1301?
CVE-2017-1301 has been scored as a medium severity vulnerability.
How to fix CVE-2017-1301?
To fix CVE-2017-1301, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-1301 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-1301 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-1301?
CVE-2017-1301 affects IBM Spectrum Protect.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.